Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP)

Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), Jean Lemerle(Institut Gustave Roussy), Catherine Patte(Institut Gustave Roussy), Martine Raphaël(University of Lausanne), S. Barsaoui, R. Bouhas(Emir Abdelkader University of Islamic Sciences), G. Rakotonirina, F. Msefer-Alaoui, Mohammed Khattab(Université Internationale Abulcasis des Sciences de la Santé), Saïd Benchekroun(Hôpital 20 Août), Claude Moreira(Cheikh Anta Diop University), P Doumbé(Yaoundé Gynaecology, Obstetrics and Pediatrics Hospital), Marie‐Anne Raquin(Institut Gustave Roussy), Yasmina Ladjaj(Hôpital Mustapha Pacha)
Pediatric Blood & Cancer
January 22, 2008
10.1002/pbc.21452
Cited by 107

Related Papers

Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
|Journal of Clinical Oncology|2015|459
Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
|Blood|2006|431
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
|Blood|2001|375
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease
|Neuro-Oncology|2013|371